Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Mar 27, 2023
POS AM Mar 24, 2023
8-K Mar 17, 2023
8-K Feb 22, 2023
8-K Feb 21, 2023
10-Q Feb 10, 2023
10-Q Nov 14, 2022
8-K Nov 1, 2022
8-K Oct 12, 2022
DEF 14C Oct 5, 2022
10-K Sep 28, 2022
8-K Sep 27, 2022
PRE 14C Sep 23, 2022
8-K Aug 18, 2022
8-K Jul 11, 2022
8-K Jul 7, 2022
DEF 14C Jun 9, 2022
PRE 14C May 27, 2022
8-K May 18, 2022
10-Q May 16, 2022
8-K Apr 18, 2022
8-K Apr 1, 2022
8-K Mar 10, 2022
424B3 Feb 22, 2022
10-Q Feb 14, 2022
← Newer Page 6 of 18 · 434 filings Older →